Genetics and genomics of pulmonary arterial hypertension

Journal of the American College of Cardiology

Volumn 62, Issue 25 SUPPL., 2013, Pages

  Soubrier, Florent ^a   Chung, Wendy K ^b   Machado, Rajiv ^c   Grünig, Ekkehard ^d   Aldred, Micheala ^e   Geraci, Mark ^f   Loyd, James E ^g   Elliott, C Gregory ^h   Trembath, Richard C ⁱ   Newman, John H ^g   Humbert, Marc ^j  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b NewYork Presbyterian Hospital   (United States)

^c UNIVERSITY OF LINCOLN   (United Kingdom)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^e LERNER RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

ⁱ KING'S COLLEGE LONDON   (United Kingdom)

^j CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

more..

Author keywords

BMPR2; genetics; genomic; pulmonary hypertension

Indexed keywords

ACTIVIN A; ACTIVIN RECEPTOR LIKE KINASE 1; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

CHROMOSOME REARRANGEMENT; CLINICAL FEATURE; CONFERENCE PAPER; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC COUNSELING; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HIGH THROUGHPUT SEQUENCING; HISTONE ACETYLATION; HISTONE METHYLATION; HUMAN; LONGITUDINAL STUDY; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; PATIENT CARE; PENETRANCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RENDU OSLER WEBER DISEASE;

BMP; BMPR2; BONE MORPHOGENETIC PROTEIN; CHD; CONGENITAL HEART DISEASE; GENETIC INFORMATION NON-DISCRIMINATION ACT; GENETICS; GENOMIC; GINA; GLYCOGEN STORAGE DISEASE; GSD; HDAC; HEREDITARY HEMORRHAGIC TELANGIECTASIA; HERITABLE PULMONARY ARTERIAL HYPERTENSION; HHT; HISTONE DEACETYLASE; HPAH; IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION; IL; INTERLEUKIN; IPAH; MESSENGER RIBONUCLEIC ACID; MICRO RIBONUCLEIC ACID; MIRNA; MRNA; PAEC; PAH; PASMC; PULMONARY ARTERIAL HYPERTENSION; PULMONARY ARTERY ENDOTHELIAL CELL; PULMONARY ARTERY SMOOTH MUSCLE CELL; PULMONARY HYPERTENSION; SINGLE NUCLEOTIDE POLYMORPHISM; SNP; TGF; TRANSFORMING GROWTH FACTOR;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMANS; HYPERTENSION, PULMONARY; MUTATION;

EID: 84890687841     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.10.035     Document Type: Conference Paper

References (104)

1. R.D. Machado, O. Eickelberg, and C.G. Elliott Genetics and genomics of pulmonary arterial hypertension J Am Coll Cardiol 54 2009 S32 S42
2. R.E. Harrison, J.A. Flanagan, and M. Sankelo Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia J Med Genet 40 2003 865 871
3. M. Shintani, H. Yagi, T. Nakayama, T. Saji, and R. Matsuoka A new nonsense mutation of SMAD8 associated with pulmonary arterial hypertension J Med Genet 46 2009 331 337
4. K.M. Drake, D. Zygmunt, and L. Mavrakis Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8 Am J Respir Crit Care Med 184 2011 1400 1408
5. M.T. Nasim, T. Ogo, and M. Ahmed Molecular genetic characterization of SMAD signaling molecules in pulmonary arterial hypertension Hum Mutat 32 2011 1385 1389
6. Z. Huang, D. Wang, K. Ihida-Stansbury, P.L. Jones, and J.F. Martin Defective pulmonary vascular remodeling in Smad8 mutant mice Hum Mol Genet 18 2009 2791 2801
7. A. Chida, M. Shintani, and T. Nakayama Missense mutations of the BMPR1B (ALK6) gene in childhood idiopathic pulmonary arterial hypertension Circ J 76 2012 1501 1508
8. L. Long, A. Crosby, and X. Yang Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease Circulation 119 2009 566 576
9. L. Ma, D. Roman-Campos, and E.D. Austin A novel channelopathy in pulmonary arterial hypertension N Engl J Med 369 2013 351 361
10. A.J. Patel, E. Honore, F. Lesage, M. Fink, G. Romey, and M. Lazdunski Inhalational anesthetics activate two-pore-domain background K+ channels Nat Neurosci 2 1999 422 426
11. M.E. Hartness, A. Lewis, G.J. Searle, I. O'Kelly, C. Peers, and P.J. Kemp Combined antisense and pharmacological approaches implicate hTASK as an airway O(2) sensing K(+) channel J Biol Chem 276 2001 26499 26508
12. A. Olschewski, Y. Li, and B. Tang Impact of TASK-1 in human pulmonary artery smooth muscle cells Circ Res 98 2006 1072 1080
13. O.N. Osipenko, A.M. Evans, and A.M. Gurney Regulation of the resting potential of rabbit pulmonary artery myocytes by a low threshold, O2-sensing potassium current Br J Pharmacol 120 1997 1461 1470
14. E. Grunig, R. Koehler, and G. Miltenberger-Miltenyi Primary pulmonary hypertension in children may have a different genetic background than in adults Pediatr Res 56 2004 571 578
15. R. Koehler, E. Grunig, and M.W. Pauciulo Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension J Med Genet 41 2004 e127
16. N. Pfarr, C. Fischer, and N. Ehlken Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension Respir Res 14 2013 3
17. R.D. Greenwood, and A.S. Nadas The clinical course of cardiac disease in Down's syndrome Pediatrics 58 1976 893 897
18. T.W. Rowland, L.G. Nordstrom, M.S. Bean, and H. Burkhardt Chronic upper airway obstruction and pulmonary hypertension in Down's syndrome Am J Dis Child 135 1981 1050 1052
19. V.L. Vida, M.A. Padalino, and G. Boccuzzo Scimitar syndrome: a European Congenital Heart Surgeons Association (ECHSA) multicentric study Circulation 122 2010 1159 1166
20. A. Tinker, N. Uren, and J. Schofield Severe pulmonary hypertension in Ullrich-Noonan syndrome Br Heart J 62 1989 74 77
21. M.S. Patel, G.P. Taylor, and S. Bharya Abnormal pericyte recruitment as a cause for pulmonary hypertension in Adams-Oliver syndrome Am J Med Genet A 129A 2004 294 299
22. A.J. Piazza, D. Blackston, and A. Sola A case of Adams-Oliver syndrome with associated brain and pulmonary involvement: further evidence of vascular pathology? Am J Med Genet A 130A 2004 172 175
23. D. Montani, F. Coulet, and B. Girerd Pulmonary hypertension in patients with neurofibromatosis type I Medicine (Baltimore) 90 2011 201 211
24. D.R. Stewart, J.D. Cogan, and M.R. Kramer Is pulmonary arterial hypertension in neurofibromatosis type 1 secondary to a plexogenic arteriopathy? Chest 132 2007 798 808
25. M. Kobayashi, M. Kondo, and Y. Mitsui Establishment of human endothelial cell lines in a serum-free culture and its application for expression of transfected prepro endothelin gene Hum Cell 4 1991 296 305
26. M.H. Alghamdi, M. Steinraths, C. Panagiotopoulos, J.E. Potts, and G.G. Sandor Primary pulmonary arterial hypertension and autoimmune polyendocrine syndrome in a pediatric patient Pediatr Cardiol 31 2010 872 874
27. D.M. Sproule, J. Dyme, and J. Coku Pulmonary artery hypertension in a child with MELAS due to a point mutation of the mitochondrial tRNA((Leu)) gene (m.3243A > G) J Inherit Metab Dis 2008 Jan 7 [E-pub ahead of print]
28. S.M. Lo, J. Liu, and F. Chen Pulmonary vascular disease in Gaucher disease: clinical spectrum, determinants of phenotype and long-term outcomes of therapy J Inherit Metab Dis 34 2011 643 650
29. T.M. Lee, E.S. Berman-Rosenzweig, A.E. Slonim, and W.K. Chung Two cases of pulmonary hypertension associated with type III glycogen storage disease JIMD Rep 1 2011 79 82
30. P.J. Engel, R.P. Baughman, S.G. Menon, D.J. Kereiakes, L. Taylor, and M. Scott Pulmonary hypertension in neurofibromatosis Am J Cardiol 99 2007 1177 1178
31. M. Nimmakayalu, H. Major, and V. Sheffield Microdeletion of 17q22q23.2 encompassing TBX2 and TBX4 in a patient with congenital microcephaly, thyroid duct cyst, sensorineural hearing loss, and pulmonary hypertension Am J Med Genet A 155A 2011 418 423
32. W.S. Kerstjens-Frederikse, E.M. Bongers, and M.T. Roofthooft TBX4 mutations (small patella syndrome) are associated with childhood-onset pulmonary arterial hypertension J Med Genet 50 2013 500 506
33. M. Germain, M. Eyries, and D. Montani Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension Nat Genet 45 2013 518 521
34. J.H. Newman, J.A. Phillips 3rd, and J.E. Loyd Narrative review: the enigma of pulmonary arterial hypertension: new insights from genetic studies Ann Intern Med 148 2008 278 283
35. S.C. Heath, I.G. Gut, and P. Brennan Investigation of the fine structure of European populations with applications to disease association studies Eur J Hum Genet 16 2008 1413 1429
36. J. West, J. Cogan, and M. Geraci Gene expression in BMPR2 mutation carriers with and without evidence of pulmonary arterial hypertension suggests pathways relevant to disease penetrance BMC Med Genomics 1 2008 45
37. S.P. Tofovic, X. Zhang, E.K. Jackson, H. Zhu, and G. Petrusevska 2-methoxyestradiol attenuates bleomycin-induced pulmonary hypertension and fibrosis in estrogen-deficient rats Vascul Pharmacol 51 2009 190 197
38. S.P. Tofovic, X. Zhang, H. Zhu, E.K. Jackson, O. Rafikova, and G. Petrusevska 2-Ethoxyestradiol is antimitogenic and attenuates monocrotaline-induced pulmonary hypertension and vascular remodeling Vascul Pharmacol 48 2008 174 183
39. R. Paulin, and E.D. Michelakis The estrogen puzzle in pulmonary arterial hypertension Circulation 126 2012 1016 1019
40. K. White, A.K. Johansen, and M. Nilsen Activity of the estrogen-metabolizing enzyme cytochrome P450 1B1 influences the development of pulmonary arterial hypertension Circulation 126 2012 1087 1098
41. J.K. Paulus, and K.E. Roberts Oestrogen and the sexual dimorphism of pulmonary arterial hypertension: a translational challenge Eur Respir J 41 2013 1014 1016
42. C. Flynn, S. Zheng, and L. Yan Connectivity map analysis of nonsense-mediated decay-positive BMPR2-related hereditary pulmonary arterial hypertension provides insights into disease penetrance Am J Respir Cell Mol Biol 47 2012 20 27
43. E.M. Mushaben, G.K. Hershey, M.W. Pauciulo, W.C. Nichols, and T.D. Le Cras Chronic allergic inflammation causes vascular remodeling and pulmonary hypertension in BMPR2 hypomorph and wild-type mice PLoS One 7 2012 e32468
44. S.H. Park, W.C. Chen, C. Hoffman, L.M. Marsh, J. West, and G. Grunig Modification of hemodynamic and immune responses to exposure with a weak antigen by the expression of a hypomorphic BMPR2 gene PLoS One 8 2013 e55180
45. E.D. Austin, J.D. Cogan, and J.D. West Alterations in oestrogen metabolism: implications for higher penetrance of familial pulmonary arterial hypertension in females Eur Respir J 34 2009 1093 1099
46. B. Sztrymf, F. Coulet, and B. Girerd Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation Am J Respir Crit Care Med 177 2008 1377 1383
47. J.R. Runo, C.L. Vnencak-Jones, and M. Prince Pulmonary veno-occlusive disease caused by an inherited mutation in bone morphogenetic protein receptor II Am J Respir Crit Care Med 167 2003 889 894
48. D. Montani, L. Achouh, and P. Dorfmuller Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology Medicine (Baltimore) 87 2008 220 233
49. D. Montani, L.C. Price, and P. Dorfmuller Pulmonary veno-occlusive disease Eur Respir J 33 2009 189 200
50. B. Girerd, D. Montani, and F. Coulet Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation Am J Respir Crit Care Med 181 2010 851 861
51. C.G. Elliott, E.W. Glissmeyer, and G.T. Havlena Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension Circulation 113 2006 2509 2515
52. D. Liu, Q.Q. Liu, and M. Eyries Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients Eur Respir J 39 2012 597 603
53. N. Pfarr, J. Szamalek-Hoegel, and C. Fischer Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations Respir Res 12 2011 99
54. E.K. Larkin, J.H. Newman, and E.D. Austin Longitudinal analysis casts doubt on the presence of genetic anticipation in heritable pulmonary arterial hypertension Am J Respir Crit Care Med 186 2012 892 896
55. D.B. Badesch, S.H. Abman, G. Simonneau, L.J. Rubin, and V.V. McLaughlin Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines Chest 131 2007 1917 1928
56. V.V. McLaughlin, S.L. Archer, and D.B. Badesch ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association Circulation 119 2009 2250 2294
57. N. Frydman, J. Steffann, and B. Girerd Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation Eur Respir J 39 2012 1534 1535
58. R. Hamid, and J. Loyd Pre-implantation genetic testing for hereditary pulmonary arterial hypertension: promise and caution Eur Respir J 39 2012 1292 1293
59. E. Grunig, B. Janssen, and D. Mereles Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene Circulation 102 2000 1145 1150
60. E. Gruenig, E. Michelakis, and J.L. Vachiery Acute hemodynamic effects of single-dose sildenafil when added to established bosentan therapy in patients with pulmonary arterial hypertension: results of the COMPASS-1 study J Clin Pharmacol 49 2009 1343 1352
61. M. Humbert, and M.M. Hoeper Severe pulmonary arterial hypertension: a forme fruste of cancer? Am J Respir Crit Care Med 178 2008 551 552
62. S.D. Lee, K.R. Shroyer, N.E. Markham, C.D. Cool, N.F. Voelkel, and R.M. Tuder Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension J Clin Invest 101 1998 927 934
63. P.R. Rai, C.D. Cool, and J.A. King The cancer paradigm of severe pulmonary arterial hypertension Am J Respir Crit Care Med 178 2008 558 564
64. R.M. Tuder, Z. Radisavljevic, K.R. Shroyer, J.M. Polak, and N.F. Voelkel Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension Am J Respir Crit Care Med 158 1998 1999 2001
65. M.E. Yeager, G.R. Halley, H.A. Golpon, N.F. Voelkel, and R.M. Tuder Microsatellite instability of endothelial cell growth and apoptosis genes within plexiform lesions in primary pulmonary hypertension Circ Res 88 2001 E2 E11
66. S.L. Archer, M. Gomberg-Maitland, M.L. Maitland, S. Rich, J.G. Garcia, and E.K. Weir Mitochondrial metabolism, redox signaling, and fusion: a mitochondria-ROS-HIF-1alpha-Kv1.5 O2-sensing pathway at the intersection of pulmonary hypertension and cancer Am J Physiol Heart Circ Physiol 294 2008 H570 H578
67. S. Bonnet, E.D. Michelakis, and C.J. Porter An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension Circulation 113 2006 2630 2641
68. I. Fijalkowska, W. Xu, and S.A. Comhair Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells Am J Pathol 176 2010 1130 1138
69. F.A. Masri, W. Xu, and S.A. Comhair Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension Am J Physiol Lung Cell Mol Physiol 293 2007 L548 L554
70. G.L. Semenza Involvement of hypoxia-inducible factor 1 in pulmonary pathophysiology Chest 128 2005 592S 594S
71. R.M. Tuder, M. Chacon, and L. Alger Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis J Pathol 195 2001 367 374
72. W. Xu, T. Koeck, and A.R. Lara Alterations of cellular bioenergetics in pulmonary artery endothelial cells Proc Natl Acad Sci U S A 104 2007 1342 1347
73. M.A. Aldred, S.A. Comhair, and M. Varella-Garcia Somatic chromosome abnormalities in the lungs of patients with pulmonary arterial hypertension Am J Respir Crit Care Med 182 2010 1153 1160
74. R.D. Machado, V. James, and M. Southwood Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension Circulation 111 2005 607 613
75. S. Sakao, L. Taraseviciene-Stewart, J.D. Lee, K. Wood, C.D. Cool, and N.F. Voelkel Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells Faseb J 19 2005 1178 1180
76. T.M. Bull, C.D. Coldren, and M. Moore Gene microarray analysis of peripheral blood cells in pulmonary arterial hypertension Am J Respir Crit Care Med 170 2004 911 919
77. M.G. Risbano, C.A. Meadows, and C.D. Coldren Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension Clin Transl Sci 3 2010 210 218
78. R. Rajkumar, K. Konishi, and T.J. Richards Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension Am J Physiol Heart Circ Physiol 298 2010 H1235 H1248
79. M. Mura, M. Anraku, and Z. Yun Gene expression profiling in the lungs of patients with pulmonary hypertension associated with pulmonary fibrosis Chest 141 2012 661 673
80. E. Hsu, H. Shi, R.M. Jordan, J. Lyons-Weiler, J.M. Pilewski, and C.A. Feghali-Bostwick Lung tissues in patients with systemic sclerosis have gene expression patterns unique to pulmonary fibrosis and pulmonary hypertension Arthritis Rheum 63 2011 783 794
81. R.J. Davies, A.M. Holmes, and J. Deighton BMP type II receptor deficiency confers resistance to growth inhibition by TGF-beta in pulmonary artery smooth muscle cells: role of proinflammatory cytokines Am J Physiol Lung Cell Mol Physiol 302 2012 L604 L615
82. M. Hecker, Z. Zaslona, and G. Kwapiszewska Dysregulation of the IL-13 receptor system: a novel pathomechanism in pulmonary arterial hypertension Am J Respir Crit Care Med 182 2010 805 818
83. E. Daley, C. Emson, and C. Guignabert Pulmonary arterial remodeling induced by a Th2 immune response J Exp Med 205 2008 361 372
84. T.P. Alastalo, M. Li, and J. Perez Vde Disruption of PPARγ/β- catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival J Clin Invest 121 2011 3735 3746
85. J. Tian, A. Smith, and J. Nechtman Effect of PPARgamma inhibition on pulmonary endothelial cell gene expression: gene profiling in pulmonary hypertension Physiol Genomics 40 2009 48 60
86. J. Loscalzo, I. Kohane, and A.L. Barabasi Human disease classification in the postgenomic era: a complex systems approach to human pathobiology Mol Syst Biol 3 2007 124
87. H. Rupani, T. Sanchez-Elsner, and P. Howarth MicroRNAs and respiratory diseases Eur Respir J 41 2013 695 705
88. R.A. McDonald, A. Hata, M.R. MacLean, N.W. Morrell, and A.H. Baker MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling Cardiovasc Res 93 2012 594 604
89. E.M. Small, and E.N. Olson Pervasive roles of microRNAs in cardiovascular biology Nature 469 2011 336 342
90. A. Courboulin, R. Paulin, and N.J. Giguere Role for miR-204 in human pulmonary arterial hypertension J Exp Med 208 2011 535 548
91. M. Brock, M. Trenkmann, and R.E. Gay Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway Circ Res 104 2009 1184 1191
92. B.N. Davis, A.C. Hilyard, G. Lagna, and A. Hata SMAD proteins control DROSHA-mediated microRNA maturation Nature 454 2008 56 61
93. V.N. Parikh, R.C. Jin, and S. Rabello MicroRNA-21 integrates pathogenic signaling to control pulmonary hypertension: results of a network bioinformatics approach Circulation 125 2012 1520 1532
94. K.M. Drake, B.J. Dunmore, L.N. McNelly, N.W. Morrell, and M.A. Aldred Correction of nonsense BMPR2 and SMAD9 mutations by ataluren in pulmonary arterial hypertension Am J Respir Cell Mol Biol 49 2013 403 409
95. B.J. Dunmore, K.M. Drake, P.D. Upton, M.R. Toshner, M.A. Aldred, and N.W. Morrell The lysosomal inhibitor, chloroquine, increases cell surface BMPR-II levels and restores BMP9 signalling in endothelial cells harbouring BMPR-II mutations Hum Mol Genet 22 2013 3667 3679
96. P. Caruso, Y. Dempsie, and H.C. Stevens A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples Circ Res 111 2012 290 300
97. S.S. Pullamsetti, C. Doebele, and A. Fischer Inhibition of microRNA-17 improves lung and heart function in experimental pulmonary hypertension Am J Respir Crit Care Med 185 2012 409 419
98. B.G. Bruneau Epigenetic regulation of the cardiovascular system: introduction to a review series Circ Res 107 2010 324 326
99. S.L. Archer, E.K. Weir, and M.R. Wilkins Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies Circulation 121 2010 2045 2066
100. C. Atkinson, S. Stewart, and P.D. Upton Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor Circulation 105 2002 1672 1678
101. I.V. Gregoretti, Y.M. Lee, and H.V. Goodson Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis J Mol Biol 338 2004 17 31
102. M.A. Cavasin, K. Demos-Davies, and T.R. Horn Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism Circ Res 110 2012 739 748
103. T.A. McKinsey Therapeutic potential for HDAC inhibitors in the heart Annu Rev Pharmacol Toxicol 52 2012 303 319
104. R. Chen, G.I. Mias, and J. Li-Pook-Than Personal omics profiling reveals dynamic molecular and medical phenotypes Cell 148 2012 1293 1307